616 related articles for article (PubMed ID: 29763365)
1. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-Fe (III) Complex as a Phosphate Chelator in Uraemic Rats: A Novel Treatment Option.
do Carmo WB; Castro BBA; Rodrigues CA; Custódio MR; Sanders-Pinheiro H
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):120-125. PubMed ID: 28727296
[TBL] [Abstract][Full Text] [Related]
3. Iron-based phosphorus chelator: Risk of iron deposition and action on bone metabolism in uremic rats.
Carmo WBD; Castro BBA; Manso LC; Carmo PAVD; Rodrigues CA; Custódio MR; Jorgetti V; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2022 Mar; 247(5):446-452. PubMed ID: 34861126
[TBL] [Abstract][Full Text] [Related]
4. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
[TBL] [Abstract][Full Text] [Related]
5. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
7. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
[TBL] [Abstract][Full Text] [Related]
8. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
De Schutter TM; Behets GJ; Geryl H; Peter ME; Steppan S; Gundlach K; Passlick-Deetjen J; D'Haese PC; Neven E
Kidney Int; 2013 Jun; 83(6):1109-17. PubMed ID: 23486515
[TBL] [Abstract][Full Text] [Related]
9. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
Cozzolino M; Dusso AS; Liapis H; Finch J; Lu Y; Burke SK; Slatopolsky E
J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974
[TBL] [Abstract][Full Text] [Related]
10. Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure.
Cernaro V; Longhitano E; Calabrese V; Casuscelli C; Di Carlo S; Spinella C; Gembillo G; Santoro D
Expert Opin Pharmacother; 2023; 24(15):1737-1746. PubMed ID: 37527180
[TBL] [Abstract][Full Text] [Related]
11. Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
Phan O; Maillard M; Malluche HH; Stehle JC; Funk F; Burnier M
Biomed Res Int; 2015; 2015():515606. PubMed ID: 26221597
[TBL] [Abstract][Full Text] [Related]
12. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
[TBL] [Abstract][Full Text] [Related]
13. Effect of iron administration on the aortic iron content and vascular calcification in phosphorus-loaded chronic kidney disease rats.
Nakanishi M; Goto A; Iwasaki T; Nakanishi T; Kuma A; Nanami M; Kuragano T
BMC Nephrol; 2023 Dec; 24(1):373. PubMed ID: 38102596
[TBL] [Abstract][Full Text] [Related]
14. Fortified phosphorus‑lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease.
Jiang J; Li Y; Zheng D; Wang Z; Zhou H; Liu G
Int J Mol Med; 2020 Nov; 46(5):1783-1793. PubMed ID: 32901861
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of linalool to ameliorate uremia induced vascular calcification in wistar rats.
Kaur T; Kaul S; Bhardwaj A
Phytomedicine; 2018 Dec; 51():191-195. PubMed ID: 30466616
[TBL] [Abstract][Full Text] [Related]
16. Can Intestinal Phosphate Binding or Inhibition of Hydroxyapatite Growth in the Vascular Wall Halt the Progression of Established Aortic Calcification in Chronic Kidney Disease?
Neven E; Opdebeeck B; De Maré A; Bashir-Dar R; Dams G; Marynissen R; Behets GJ; Verhulst A; Riser BL; D'Haese PC
Calcif Tissue Int; 2016 Nov; 99(5):525-534. PubMed ID: 27461215
[TBL] [Abstract][Full Text] [Related]
17. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F
J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of iron overloading on vascular calcification in uremic rats.
Seto T; Hamada C; Tomino Y
J Nephrol; 2014 Apr; 27(2):135-42. PubMed ID: 24500887
[TBL] [Abstract][Full Text] [Related]
19. Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
Terai K; Nara H; Takakura K; Mizukami K; Sanagi M; Fukushima S; Fujimori A; Itoh H; Okada M
Br J Pharmacol; 2009 Apr; 156(8):1267-78. PubMed ID: 19302594
[TBL] [Abstract][Full Text] [Related]
20. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]